VEGFA and age-related macular degeneration: In their study, several dysregulated proteins were speculated to be potential biomarkers to distinguish AMD patients with different responses to anti-VEGF agents, and among these, LCN1 and the heavy chain component of IGHM were upregulated in the good response group and downregulated in the anti-VEGF poor response group.